This compound is a pharmaceutical intermediate featuring a thiazole ring and a cyano-substituted phenyl ether structure. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 160844-75-7
Febuxostate
active pharmaceutical ingredient
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
pharmaceutical intermediate
1-[7-Amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]ethanone
Pharmaceutical intermediate for synthesis
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl Methanesulfonate
pharmaceutical intermediate
3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene
Pharmaceutical intermediate for sulfonamide synthesis
Ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
OGAZOYHQFBSRMC-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)OCC(C)C)C#N)C